Cargando…
Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE(2)
PURPOSE: 83b1 is a novel quinoline derivative that has been shown to inhibit cancer growth in human esophageal squamous cell carcinoma (ESCC). This study was conducted to comprehensively evaluate the cytotoxic effects of 83b1 on a series of ESCC cell lines and investigate the mechanisms by which 83b...
Autores principales: | Pun, Ivan Ho Yuen, Chan, Dessy, Chan, Sau Hing, Chung, Po Yee, Zhou, Yuan Yuan, Law, Simon, Lam, Alfred King Yin, Chui, Chung Hin, Chan, Albert Sun Chi, Lam, Kim Hung, Tang, Johnny Cheuk On |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266386/ https://www.ncbi.nlm.nih.gov/pubmed/27456944 http://dx.doi.org/10.4143/crt.2016.190 |
Ejemplares similares
-
Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
por: Zhou, Yuanyuan, et al.
Publicado: (2019) -
Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
por: Chan, Dessy, et al.
Publicado: (2018) -
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican
por: Zhou, Yuanyuan, et al.
Publicado: (2022) -
COX2 regulates senescence secretome composition and senescence surveillance through PGE(2)
por: Gonçalves, Susana, et al.
Publicado: (2021) -
COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020)